Alpha Tau Medical Ltd (DRTS)
2.45
-0.01
(-0.41%)
USD |
NASDAQ |
May 07, 16:00
2.49
+0.04
(+1.63%)
After-Hours: 20:00
Alpha Tau Medical Research and Development Expense (Quarterly): 7.49M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.49M |
| September 30, 2023 | 6.673M |
| June 30, 2023 | 5.955M |
| March 31, 2023 | 6.306M |
| December 31, 2022 | 5.38M |
| September 30, 2022 | 4.827M |
| Date | Value |
|---|---|
| June 30, 2022 | 5.448M |
| March 31, 2022 | 5.235M |
| December 31, 2021 | 3.229M |
| September 30, 2021 | 3.032M |
| June 30, 2021 | 2.997M |
| March 31, 2021 | 2.189M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.189M
Minimum
Mar 2021
7.49M
Maximum
Dec 2023
4.897M
Average
5.308M
Median
Research and Development Expense (Quarterly) Benchmarks
| Taro Pharmaceutical Industries Ltd | 13.59M |
| InspireMD Inc | 2.035M |
| BiomX Inc | 2.675M |
| Pluri Inc | 2.964M |
| Holdco Nuvo Group DG Ltd | -- |